Literature DB >> 6399695

Adjuvant use of cytotoxic chemotherapy to destroy micrometastasis in breast cancer after local control therapy--current status.

S K Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6399695     DOI： 10.1007/BF00118468

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN： 0262-0898            Impact factor:   5.150


× No keyword cloud information.
  15 in total

1.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

Review 2.  Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer.

Authors:  R Nissen-Meyer; K Kjellgren; K Malmio; B Månsson; T Norin
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

4.  Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

Authors:  B Fisher; N Slack; D Katrych; N Wolmark
Journal:  Surg Gynecol Obstet       Date:  1975-04

5.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

6.  Treatment of primary breast cancer with chemotherapy and tamoxifen.

Authors:  B Fisher; C Redmond; A Brown; N Wolmark; J Wittliff; E R Fisher; D Plotkin; D Bowman; S Sachs; J Wolter; R Frelick; R Desser; N LiCalzi; P Geggie; T Campbell; E G Elias; D Prager; P Koontz; H Volk; N Dimitrov; B Gardner; H Lerner; H Shibata
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

7.  Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.

Authors:  A Glass; H S Wieand; B Fisher; C Redmond; H Lerner; J Wolter; H Shibata; D Plotkin; R Foster; R Margolese; N Wolmark
Journal:  Cancer Treat Rep       Date:  1981 May-Jun

8.  Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.

Authors:  A U Buzdar; G R Blumenschein; J U Gutterman; C K Tashima; G N Hortobagyi; T L Smith; L T Campos; W L Wheeler; E M Hersh; E J Freireich; E A Gehan
Journal:  JAMA       Date:  1979-10-05       Impact factor: 56.272

9.  The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.

Authors:  B Fisher; C Redmond; E R Fisher
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

10.  Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients.

Authors:  P Valagussa; G Bonadonna; U Veronesi
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.